Term of License Grant. The license granted to the MPP in Section 2.1 with respect to Licensed Patent Rights will expire upon the expiration of the last-to-expire of the Licensed Patent Rights that are granted and in force in that particular country, unless where terminated earlier in accordance with Section 12. Following the expiration of such licenses in the Territory, the licenses granted in Section 2.1 with respect to Licensed Manufacturing Know-How will be fully paid-up and perpetual.
Term of License Grant. The license granted to the Sublicensee in Section 2.1 with respect to Licensed Patent Rights will expire upon the expiration of the last-to-expire of the Licensed Patent Rights that are granted and in force in that particular country, unless where terminated earlier in accordance with Section 12. Following the expiration of such licenses in the Territory, the licenses granted in Section 2.1 with respect to Licensed Manufacturing Know-How will be fully paid-up and perpetual.
Term of License Grant. Unless terminated earlier as provided below, each such License to a Licensed Antibody Product in a country shall commence on the date that Pfizer first exercises its option pursuant to Section 2.1 and shall terminate on the the last to expire of the Patent Rights in such country with respect to such Licensed Antibody Product.
Term of License Grant. Unless terminated earlier as provided below, the License shall commence on the Effective Date and shall terminate in each country in the Territory on the date on which the last to expire of the Patent Rights expires.
Term of License Grant. The term of the license granted under ARTICLE I shall end on the TERMINATION DATE unless sooner terminated.
Term of License Grant. The term of the Product License shall be perpetual, unless terminated in accordance with provisions in this Agreement.
Term of License Grant. The license granted to GARDP in Section 2.1 with respect to Licensed Rights will expire upon the expiry of the Term, subject to an earlier termination in accordance with Section 12.
Term of License Grant. The licenses granted pursuant to this Article 2 and the obligations of Inpixon arising in connection therewith shall be deemed effective as of the Effective Date and shall continue for a term of fifteen (15) years from the Closing Date, until terminated pursuant to the terms set forth in Article 5 (the “License Term”).
Term of License Grant. Unless terminated earlier pursuant to Section 10, the License in each country shall commence on the Effective Date, and shall terminate, on a country-by-country basis on the latest date on which the Licensed Product is covered by a Valid Claim under the IMMUCELL Patent Rights in that country, or ten (10) years from the Launch of the Licensed Product in such country, whichever is later (the “Initial Term”); provided, however, that any time prior to termination of the Initial Term the parties may jointly agree in writing to extend the Initial Term for an additional three (3) year period, and thereafter may at any time jointly agree in writing to extend any such renewal term(s) for successive three-year periods (each, a “Renewal Term” and collectively with the Initial Term, the “Term”).
Term of License Grant. Upon the District Court signing and entering the Stipulated Order of Dismissal and upon full payment of the Settlement Amount, the rights granted in Section 5 shall take effect as of the Effective Date and shall continue until the last to expire of the Subject Product Patent Rights.
